Daihong Liu
Daihong Liu
Explore linked clinical trials.13 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RCT of Population PK-guided ATG Dosing in Haplo-HSCT | Hematopoietic Stem Cell Transplantation | Recruiting | Phase 3 | 2026-10-07 | NCT07862127 | |
| EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation | EBV-DNA Viremia | Recruiting | Phase 1 | 2026-08-06 | NCT07438067 | |
| Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation | Recruiting | Phase 4 | 2026-06-15 | NCT07648992 | |
| Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host Disease | Acute Graft-versus-host Disease | Active, not recruiting | Phase 1 | 2026-06-15 | NCT07576010 | |
| Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) | acute graft versus host disease, graft versus host disease, immune system disorder | Recruiting | Phase 2 | 2026-04-03 | NCT07509749 | |
| Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination. | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-03-24 | NCT07489989 | |
| Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction | Blood Protein Disorders, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Urogenital Diseases, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, kidney disorder, kidney failure, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, urinary system disorder, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-03-24 | NCT07489534 | |
| EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders | EBV-Positive Lymphoma; Epstein-Barr Virus-Associated Lymphoproliferative Disorders | Recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT07450391 | |
| Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, post-transplant lymphoproliferative disease, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-01-28 | NCT07368634 | |
| Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) | GVHD,Acute; Stem Cell Transplant Complications | Recruiting | Phase 2 | 2026-01-14 | NCT07340723 | |
| Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia | B-cell Lymphoma Refractory | Recruiting | Phase 2 | 2026-01-07 | NCT07321301 | |
| Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2025-07-30 | NCT07094477 | |
| Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2025-07-30 | NCT07094464 |